Login / Signup

Establishing a standardized system for review and adjudication of chronic graft-vs-host disease data in accordance with the National Institutes Consensus criteria.

Djamilia DierovNicholas WebbSamira FatmiChamberlain NwanneCristi CiolinoKara MosessoJimmy NievesMiguel-Angel PeralesSusan E ProckopDoris M Ponce
Published in: Advances in cell and gene therapy (2019)
GVHD is a frequent complication following allo-HCT. The NIH consensus group established new guidelines for the evaluation of chronic GVHD. However, GVHD assessment remains challenging due its complexity and requirement for laborious evaluation. We, therefore, established a standardized approach for the assessment of chronic GVHD in accordance with the NCC guidelines. At a single institution, all allograft recipients were evaluated for GVHD within the first-year post allo-HCT following a 3-step workflow (real-time assessment, consensus review, and documentation). A GVHD adjudication committee was created and a dynamic electronic GVHD data capture form was developed guiding the clinician through a comprehensive review of systems following the NCC guidelines. We found that the assessment and reporting of GVHD reached 100% compliance. The establishment of an institutional GVHD adjudication committee enabled standardized assessment of GVHD. Our workflow can be adopted by other centers to create a similar framework for dedicated GVHD evaluation.
Keyphrases
  • allogeneic hematopoietic stem cell transplantation
  • electronic health record
  • clinical practice
  • acute myeloid leukemia
  • emergency department
  • cell proliferation
  • quality improvement